PT  - JOURNAL ARTICLE
AU  - Zeilinger, Elisabeth L.
AU  - Nader, Ingo W.
AU  - Jomar, Dana
AU  - Zauchner, Clemens
TI  - Onset of effects of non-pharmaceutical interventions on COVID-19 worldwide
AID  - 10.1101/2020.09.02.20185660
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.02.20185660
4099  - http://medrxiv.org/content/early/2020/09/03/2020.09.02.20185660.short
4100  - http://medrxiv.org/content/early/2020/09/03/2020.09.02.20185660.full
AB  - During the initial phase of the global COVID-19 outbreak, most countries responded with non-pharmaceutical interventions (NPIs). The effectiveness of these NPIs has been investigated with simulation studies, that rely on assumptions and by empirical studies with few countries and controversial results. However, it has not been investigated in detail how long different NPIs need to be in place to take effect, or how long they should be in place for their maximum effect to unfold. We used global data and a non-parametric machine learning model to estimate the effects of NPIs in relation to how long they have been in place. Here we show that closure and regulation of schools was the most important NPI, associated with a pronounced effect about 10 days after implementation. Restrictions of mass gatherings and restrictions and regulations of businesses were found to have a more gradual effect, and social distancing was associated with a delayed effect starting about 18 days after implementation. Generally, effects increased until about 40 to 50 days after implementation. Our results can inform political decisions regarding the choice of NPIs and how long they need to be in place to take effect.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No ethical approval was necessary due to the nature of the study.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in this analysis is publicly available. The time series of cumulative confirmed COVID-19 cases was downloaded from https://data.humdata.org/dataset/novel-coronavirus-2019-ncov-cases, the government response dataset (CoronaNet) was downloaded from https://github.com/saudiwin/corona_tscs, and the Word Banks development indicators were downloaded via the R package wbstats.31 The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.